Jaw Avascular Osteonecrosis after Treatment of Post-menopausal Osteoporosis with Residronate: A Case Report
نویسندگان
چکیده
منابع مشابه
Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) occurs mainly in female patients. In males the occurrence rate is low, which seems to be related to the low incidence of osteoporosis in men. Unfortunately, BRONJ tends to be ignored in general dental clinics in male patients with a history of osteoporosis treatment. BRONJ occurred in a male patient due to the clinician's lack of interest ...
متن کاملOsteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
Bisphosphonates are a common treatment for osteoporosis. Osteonecrosis of the jaw has been associated with the use of bisphosphonates, usually when they have been used parenterally to treat malignancies. Cases associated with oral bisphosphonate as a treatment for osteoporosis are less frequent. We describe two patients exhibiting the clinical manifestations of bisphosphonate-associated osteone...
متن کاملBisphosphonates and Osteonecrosis of the Jaw: A Case Report
The incidence of bone metastases is high among patients with advanced cancer. Bone metastases occur in about 80% of men with advanced prostate cancer, 75% of patients with metastatic breast cancer and 30% to 60% of patients with advanced metastatic lung cancer, and are present in 35% of patients with renal cell carcinoma at the time of diagnosis. Bone metastases cause considerable skeletal morb...
متن کاملPost-menopausal Osteoporosis
Millions of women will be prescribed hormone replacement therapy (HRT) and be told that it will prevent osteoporosis occurring, despite the fact that there is doubt about its long term usefulness. Preventive measures outlined in this article are much more preferable, but need to be directed towards the whole population, not just menopausal women. The prevention of osteoporosis is an important p...
متن کاملAvascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
of ONJ [6–8], although such reports in the context of the large phase III trials of these agents are lacking. These reports included patients treated with sunitinib, an inhibitor of the tyrosine kinases of VEGF, PDGF, c-kit, FLT3 and RET, or bevacizumab, a monoclonal antibody, which solely inhibits VEGF. Taken together these reports underline the importance of VEGF in the development of ONJ. Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Case Reports
سال: 2015
ISSN: 2165-7920
DOI: 10.4172/2165-7920.1000543